Company Profile
ASCLETIS-B
Description
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company offers Ritonavir tablet; and ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Ascletis Pharma Inc. was founded in 2013 and is headquartered in Hangzhou, the People's Republic of China.
Reports
This company has 1 ESG reports available.
ESG Performance Overview
Select a KPI indicator to view performance trend
KPI Indicators
A1.2 Direct (Scope 1) and Indirect (Scope 2) GHG Emissions
6 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Total GHG Emissions Intensity (By Employee) | 1 | |
| Total GHG Emissions Intensity (By Area) | 1 | |
| Total GHG Emissions | 1 | |
| Direct GHG Emissions (Scope 1) | 1 | |
| Indirect Energy Emissions (Scope 2) | 1 | |
| Total Other Indirect Energy Emissions (Scope 3) | 1 |
A1.3 Hazardous Waste
4 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Hazardous Waste (Solid Waste) | 1 | |
| Hazardous Waste (Liquid Waste) | 1 | |
| Total Hazardous Waste Intensity (By Employee) | 1 | |
| Total Hazardous Waste | 1 |
A2.1 Energy Consumption
5 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Total Electricity Consumption Intensity (By Employee) | 1 | |
| Total Electricity Consumption Intensity (By Area) | 1 | |
| Gasoline Consumption | 1 | |
| Total Indirect Energy Consumption | 1 | |
| Purchased Electricity | 1 |
A2.2 Water Consumption
1 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Water Consumption | 1 |
B1.1 Amount and Distribution of Workforce
11 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Number of Total Employees | 1 | |
| Number of Male Employees | 1 | |
| Number of Female Employees | 1 | |
| Percentage of Male Employees | 1 | |
| Percentage of Female Employees | 1 | |
| Number of Employees Aged Below 30 | 1 | |
| Number of Employees Aged 30-50 | 1 | |
| Number of Employees Aged Above 50 | 1 | |
| Percentage of Employees Aged Below 30 | 1 | |
| Percentage of Employees Aged 30-50 | 1 | |
| Percentage of Employees Aged Above 50 | 1 |
B2.1 Number and Rate of Work-related Fatalities
2 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Number of Work-related Fatalities | 1 | |
| Number of Fatalities as a Result of Work-related Injuries | 1 |
B3.1 The Percentage of Employees Trained
2 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Percentage of Trained Male Employees | 1 | |
| Percentage of Trained Female Employees | 1 |
B3.2 Average Training Hours Completed per Employee
2 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Average Training Hours (Male) | 1 | |
| Average Training Hours (Female) | 1 |
ESG Reports
| Year | Report Title | Publication Date | Raw KPIs | Standard KPIs | Processed | Actions |
|---|---|---|---|---|---|---|
| 2018 | ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2018 | 2019-07-19 | 43 | 33 | Yes |